“Crystal Meth” Street methamphetamine aka: • • • • • • "speed," "meth," "chalk." “crank” Pepsi means crank Pepsi one means Crystal Methamphetamine hydrochloride: (smokable clear chunky crystals resembling ice) • "ice,“cristy” “glass” “hanyak” “L.A.” “quartz” "crystal” Quantities: • • • “paper” = ¼
Download ReportTranscript “Crystal Meth” Street methamphetamine aka: • • • • • • "speed," "meth," "chalk." “crank” Pepsi means crank Pepsi one means Crystal Methamphetamine hydrochloride: (smokable clear chunky crystals resembling ice) • "ice,“cristy” “glass” “hanyak” “L.A.” “quartz” "crystal” Quantities: • • • “paper” = ¼
“Crystal Meth” Street methamphetamine aka: • • • • • • "speed," "meth," "chalk." “crank” Pepsi means crank Pepsi one means Crystal Methamphetamine hydrochloride: (smokable clear chunky crystals resembling ice) • "ice,“cristy” “glass” “hanyak” “L.A.” “quartz” "crystal” Quantities: • • • “paper” = ¼ gram “Teenager” = 1/16 oz. “Eightball” - (eighth of an ounce) = 3.5 grams • Tina Or Teena - name derives from the fact that meth is commonly bought in sixteenths of an ounce packages (aka "baggies") “Tweaking” www.tweaker.org Someone who uses meth. Often refers only to those who get paranoid or psychotic. History of Methamphetamine • • • • • • • • Amphetamines were synthesized by the German pharmacologist L. Edeleano in 1887. The related compound, methamphetamine, was first synthesized in Japan in 1919. In 1927 The British chemist Gordon Alles discovered the stimulating effects of meth. In 1932, an U.S. pharmaceutical company bought the patent to the Alles discovery, and marketed the drug as a nasal decongestant that could be inhaled, Benzedrine.(Bennies) People used to take apart those inhalers and suck-out the speed. During the WWII, amphetamines were sanctioned by a number of governments including Nazi Germany, the United States and Japan for their energizing troops and antidepressant properties. A friendly fire incident in Afghanistan last year has turned the spotlight on amphetamine use by US Air Force pilots. Four Canadians were killed and eight injured when two US pilots misinterpreted their night-time exercises as an attack and dropped a bomb. This was despite the Canadian forces informing the US military of the manoeuvres, and in contravention of orders directing the pilots to hold their fire. The pilots now face court martial, with much of the attention focused on whether the amphetamines in their system made them trigger-happy. It is estimated that millions of Japanese soldiers, defense workers, and civilians used amphetamines and that by the end of the war, at least 2 percent of the adult Japanese population were dependent on the drug. In the United States, post-war studies of American military prisoners revealed abuse of amphetamine inhalers. In 1959, the first use in the United States of intravenous injection of the contents of a Benzedrine inhaler for non-medicinal purposes was reported; in 1971, the last non-prescription inhaler was removed from the U.S. market pursuant to the passage of the Controlled Substances Act of 1970. In the United States, there have been three distinct methamphetamine epidemics: one in the Street Cost of Methamphetamine: A Cheap Date? • One ounce of meth equals about 110 meth "hits." $25 per 1/4 gram $ 100 per gram $1700 per ounce Nationwide, prices ranged from $12,000 to $35,000 per kilogram of Cocaine. 0.5gm which would cost between $60 and $100. 1 oz cocaine= $2800 Oct. 9, 1999 New York March 28, 2000 Bay Area of California 1/4 gram - $60 1 gram - $240 1/4 gram - $20 1 gram - $80 Before and After Methamphetamine Treatment Admissions 1992 Methamphetamine Treatment Admissions 1996 Methamphetamine a “cottage industry” National Clandestine Laboratory Epidemic or Not? • • • • According to the New York City's largest private clinic for lesbians and gay men, Callen-Lorde Community Health Center, two-thirds of those testing positive for H.I.V. since June acknowledged that crystal meth was a factor in their infection. Dr. Howard Grossman, one of the city's best-known AIDS specialists, said more than half the men who test positive in his private practice blamed methamphetamine. "This drug is destroying our community," he said. "It just seems to be getting worse and worse, and no one is doing anything about it." Although the city Department of Health does not track crystal meth use among the newly infected, the city's poison control center received four dozen reports of crystal meth overdoses in 2002 and 2003. In the previous two years, there were none, said the city's health commissioner, Thomas R. Frieden. In another survey, the agency found that H.I.V.positive men were twice as likely as uninfected men to use methamphetamine; those who use the drug were also less likely than other men to wear condoms during anal intercourse. "We're seeing a general increase in risky sexual behavior, and we're concerned," Dr. Frieden said. Nearly two dozen 12-step meetings are held each week around the city for those trying to shake the drug. In 2002, there were four Crystal Meth Anonymous meetings each week. In 1999, there were none. Geographical method of usage varies A recent study by the Center for H.I.V./AIDS Educational Studies and Training found that more than half of gay men in New York who admitted using alcohol or drugs had tried crystal meth in the previous year. By comparison, a 1998 survey conducted at bars and clubs by the center found that 10 percent of gay men said they had tried it. • • • According to the 2000 National Household Survey on Drug Abuse, an estimated 8.8 million people(4.0 percent of the population) have tried methamphetamine at some time in their lives. Data from the 2000 Drug Abuse Warning Network (DAWN), which collects information on drug-related episodes from hospital emergency departments in 21 metropolitan areas, reported that methamphetamine related episodes increased from approximately 10,400 in 1999 to 13,500 in 2000, a 30 percent increase. However, there was a significant decrease in methamphetamine-related episodes reported between 1997 (17,200) and 1998 (11,500). $25 will keep a user high for a day on a mere quarter gram of methamphetamine. Decreased Striatal Dopamine D1 Receptor-Stimulated Adenylyl Cyclase Activity in Human Methamphetamine Users Junchao Tong, Ph.D. Brian M. Ross, Ph.D. Gregory A. Schmunk, M.D. Frank J. Peretti, M.D. Kathryn S. Kalasinsky, Ph.D. Yoshiaki Furukawa, M.D. Lee Cyn Ang, M.D. Sally S. Aiken, M.D. Dennis J. Wickham, M.D. Stephen J. Kish, Ph.D. (Am J Psychiatry 2003; 160:896–903) Emotional & Social Consequences • • • • • • • Delinquency School Problems School Absenteeism Criminal Behavior Homelessness Shame Attachment Disorders • • • • • • • Isolation Poor Peer Relations Unemployment Poverty Addictions Poor Anger Mgmt. Chaotic Lifestyle Symptoms of Methamphetamine Use/Abuse • Increased alertness & activity, with a feeling of euphoria & selfconfidence • Mood disturbances & delusional sensory experiences, such as bugs crawling on the skin • Elevated heart rate, respiration & body temperature • Blurred vision • Dizziness • Welts on the skin • Rotten teeth • Severe weight loss • Dilated pupils Meth “Binge & Crash” • Binge: can last up to 3 days characterized by redosing in effort to obtain original rush, close with period of confusion, “tweaking” • Crash has 4 phases: – 1. Insomnia, exhaustion, fatigue, paranoia, auditory hallucinations, violence, irritability, aggression – 2. Intense sleep: up to 3 days, body can starve & begin to catabolize muscle: danger of coma & seizures – 3. Intense hunger, eating, disorientation, depression – 4. Depression: lasting up to 5 months Dopamine Transporter binding in chronic Methamphetamine Abusers Methamphetamine-Related Psychiatric Symptoms and Reduced Brain Dopamine Transporters Studied With PET (Am J Psychiatry 2001; 158:1206–1214) Yoshimoto Sekine, M.D., Ph.D. Masaomi Iyo, M.D., Ph.D. Yasuomi Ouchi, M.D., Ph.D. Tsutomu Matsunaga, M.D., Ph.D. Hideo Tsukada, Ph.D. Hiroyuki Okada, B.A. Etsuji Yoshikawa, B.A. Masami Futatsubashi, B.A. Nori Takei, M.D., Ph.D., M.Sc. Norio Mori, M.D., Ph.D. Limbic System Dopamine Transporter binding in chronic Methamphetamine Abusers • We found no significant correlation between the duration of abstinence, which lasted in our subjects from 1 week to 1.5 years, and dopamine transporter density in either the caudate/putamen or the nucleus accumbens. • The previous PET study (15) showed a significant reduction in the caudate/putamen dopamine transporter density in chronic methamphetamine users, some of whom had been abstinent for more than 3 years. • These findings suggest that lasting reduction of brain dopamine transporter density could occur after habitual methamphetamine use. Methamphetamine and D2 Receptor Availability (Am J Psychiatry 158:12, December 2001 VOLKOW, CHANG, WANG, ET AL.) Pathways of Addiction •The first PET study to document lower levels of dopamine D2 receptors in methamphetamine abusers. PET measures of dopamine D2 receptors mostly reflect the level of postsynaptic receptors •Lower levels of D2 receptor availability in methamphetamine abusers could reflect receptor down-regulation from exposure to a higher extracellular dopamine concentration secondary to methamphetamine’s acute pharmacological effects. •Alternatively, the low levels of D2 receptors could have preceded methamphetamine use and may have predisposed these subjects to drug use. •Subjects with low D2 receptor levels experienced a “pleasurable” response, whereas subjects with high receptor levels experienced an “unpleasant” response. These findings led us to speculate that D2 receptors, by modulating pleasant versus unpleasant drug responses, may be a variable that contributes to drug abuse and addiction. Dopamine Neuron destruction • Chronic administration of morphine in rats shrinks dopamine neurons in the reward circuit. The receiving branches, called dendrites, wither and the filaments that transport important substances down the neuron's axon are reduced. Nerve growth factors appear to reverse the damage. Illustration by Lydia Kibiuk, Copyright © 1997 Lydia Kibiuk. Orbitofrontal Cortex Dopamine modulation of the orbitofrontal cortex could underlie addictive behaviors in several ways. First, the orbitofrontal cortex is involved in the regulation of “drive” , and thus enhanced activation secondary to drug-induced dopamine stimulation could result in an intense motivation to self-administer methamphetamine in the addicted subjects. Moreover, because the orbitofrontal cortex processes information about the rewarding properties of stimuli, its disruption could account for the enhanced salience of drug-related stimuli. Second, the orbitofrontal cortex has been implicated in the occurrence of compulsive behaviors, and thus one could postulate that its inappropriate activation could induce compulsive drug administration in methamphetamine abusers. In laboratory animals, damage to the orbitofrontal cortex results in perseveration and resistance to extinction of reward-associated behaviors . These findings are reminiscent of the reports of drug addicts who claim that once they start taking a drug of abuse they cannot stop even when the drug is no longer pleasurable. Third, the orbitofrontal cortex is involved with learning stimulus-reinforcement associations and with conditioned responses and could therefore participate in cues or drug-induced craving. Laboratory animals exposed to an environment where they had received a drug of abuse show orbitofrontal activation (49), and lesions of the orbitofrontal cortex interfere with drug-induced conditioned place preference (50). These findings are relevant because drug-induced conditioned responses have been implicated in the craving elicited in humans by drug-related stimuli (51), which is one of the factors that contributes to relapse in drug abusers (52). Moreover, activation of the orbitofrontal cortex has been shown in drug abusers during craving elicited by a drug (53), by viewing a video of drug paraphernalia (54), and by recalling previous drug experiences (55). Limitations for this study are those inherent in clinical research in drug abuse populations, Human Genome • The results showed that the gene whose expression was stimulated to the greatest degree by the methamphetamine was a G protein receptor kinase, called GRK3. GRK3 in the rat genome is analogous to the region 22q11 on the human genome, the area where several laboratories, including ours, have identified an association with both bipolar illness and schizophrenia. This close proximity of a susceptibility gene for bipolar disorder/schizophrenia with a gene that is activated by methamphetamine in rat brain strengthens the claim that this preparation is a model for manic psychosis. ALEXANDER B. NICULESCU III, M.D., PH.D. JOHN R. KELSOE, M.D. San Diego, Calif. Reward/Punishment activation of the Orbital Frontal Cortex Reward Activation Punishment Activation Reward/Punishment activation of the Orbital Frontal Cortex • • • University of Oxford study using fMRI. Choice of the correct stimulus led to a probabilistically determined ‘monetary’ reward and choice of the incorrect stimulus led to a monetary loss. These results are consistent with the hypothesis that the deficits in emotion-related learning tasks following OFC lesions are due to an impairment in using information from rewarding and punishing outcomes to guide behavioral choice. The finding that the magnitude of the activations depended on the size of the reward or punishment received is consistent with neurophysiological evidence from primates that rewarding and punishing stimuli are represented in the OFC, but this finding does not exclude a possible representation in other brain areas of rewards and punishments. Our evidence that there is a representation for rewards and punishments in these regions is also consistent with the hypothesis that the changed emotional and social behavior demonstrated by humans with this damage is due to a fundamental impairment in the processing of rewards and punishments. Reward and punishment representations in the human orbito-frontal cortex J. O’Doherty1,2, M. L. Kringelbach1,2, E. T. Rolls1, J. Hornak1 and C. Andrews2 nature neuroscience • volume 4 no 1 • january 2001 CNS • Even small amounts of methamphetamine can produce euphoria, increased alertness, paranoia, decreased appetite and increased physical activity. Other central nervous system effects include athetosis (writhing jerky, or flailing movements), irritability, extreme nervousness, insomnia, confusion, tremors, anxiety, aggression, incessant talking, hyperthermia, and convulsions. Hyperthermia (extreme rise in body temperature as high as 108 degrees) and convulsions sometimes can result in death. Physical • Use can produce chest pain and hypertension which can result in cardiovascular collapse and death. In addition, methamphetamine causes accelerated heartbeat, elevated blood pressure and can cause irreversible damage to blood vessels in the brain. Pupil dilation, respiratory disorders, dizziness, tooth grinding, impaired speech, dry or itchy skin, loss of appetite, acne, sores, numbness, and sweating. Overdose • A toxic reaction (or overdose) can occur at relatively low levels, 50 milligrams of pure drug for a non-tolerant user. Withdrawal • drug craving, extreme irritability, loss of energy, depression, fearfulness, excessive drowsiness or difficulty in sleeping, shaking, nausea, palpitations, sweating, hyperventilation, and increased appetite. Treatment • Acute Restorative Treatment (im Ativan for rapid tranquilization, intravenous hydration for electrolytes, vitamin, diet) • Infectious Disease Evaluation (HIV, Hepatitis profile, Heterophile, Gonococcal etc.) • CMA (Crystal Meth Anonymous), AA, SAA • Antidepressants (Wellbutrin), refrain from Major Tranquilizers when possible, AED preferable for agitated mood symptomatology • Individual Therapy > 1year • Small Group Therapy with daily internet message group interaction People, Places and Things The idea of encoding drug-induced behavioral changes in a memory-like fashion permits the incorporation of a commonly observed clinical characteristic of addiction, namely that drug-associated environmental stimuli have inordinate power to direct behavior (3). Indeed, drug-seeking by addicts is often described as an almost unconscious behavior that is seemingly immune from conscious control. As such, these behaviors can be viewed as a form of procedural memory that is triggered by environmental stimuli indicative of the drug experience. Procedural memories are encoded in a distributed circuit that integrates the association cortex with the basal ganglia, thalamus, and limbic nuclei. However, even as this synthesis of information regarding the acute effects of drugs was pointing researchers toward the importance of dopamine in reward and reinforcement, it was becoming ever more apparent that addiction produced by chronic drug use was associated with long-term changes in brain circuitry distal to dopamine transmission. Moreover, it appeared possible that these nondopaminergic neuroadaptations were encoding the behavioral changes that define addiction Homosexual Issues • • • • • • Bathhouse behaviors HIV/HepC/Syphilis Viagra “Meth eventually turns everyone into a bottom” Obsessive/Compulsive sexual urges As long as it took to get into the forest, as long as to get out:patience above ALL ELSE Future Treatments • Researchers are testing unique methods that may help abusers stay off drugs and treat an overdose. One technique (a) works like a traditional vaccine. It attempts to prompt the immune system to send out a slew of antibodies that trap and inactivate target drugs. Another strategy (b) involves lab-manufacturing a selection of the most aggressive antibodies. A dose of the medicine also is thought to trap and inactivate target drugs. In a different technique under investigation (c) specially created antibodies attack and then chew up the drug. ILLUSTRATION BY LYDIA KIBIUK. Copyright © 2001. Meth Effects